<DOC>
	<DOCNO>NCT01240603</DOCNO>
	<brief_summary>Plasmodium falciparum parasite clearance rate ( PCRs ) oral artesunate treatment patient uncomplicated malaria recently find significantly slow Pailin ( Western Cambodia ) compare Wang Pha ( Eastern Thailand ) . This difference PCRs attribute different history artesunate drug pressure two area . In Pailin , artesunate monotherapy use inappropriately 30 year hypothesize select artemisinin-resistant parasite ( slow PCRs ) . To investigate potential contribution human factor artemisinin resistance phenotype , identify study site Eastern Cambodia artemisinin-resistant parasite believe present . The main aim study 1 ) determine whether artemisinin resistance phenotype ( i.e. , half-life long 2-hour half-life observe Wang Pha ) present Eastern Cambodia , 2 ) determine whether hemoglobin E affect parasite clearance rate vivo , 3 ) determine whether age-associated acquire immunity affect parasite clearance rate vivo , 4 ) identify parasite-heritable trait associate slow parasite clearance rate vivo . To meet aim , conduct prospective , longitudinal study recruit Cambodian resident Lumphat District Ratanakiri Province complain fever and/or symptom malaria . Patients diagnose uncomplicated malaria treat weight-based dos artesunate give orally day 3 day follow mefloquine give orally 2 day . During time , finger prick blood smear obtain every 6 hour parasite density zero . From data , estimate parasite clearance rate use half-life parameter . We also collect parasitized red blood cell sample malaria patient prior antimalarial drug administration . These parasite test short-term vitro culture experiment determine susceptibility artemisinins antimalarial drug ... .</brief_summary>
	<brief_title>Plasmodium Falciparum Clearance Rates Response Artesunate Eastern Cambodia</brief_title>
	<detailed_description>Plasmodium falciparum parasite clearance rate ( PCRs ) oral artesunate treatment patient uncomplicated malaria recently find significantly slow Pailin ( Western Cambodia ) compare Wang Pha ( Eastern Thailand ) . This difference PCRs attribute different history artesunate drug pressure two area . In Pailin , artesunate monotherapy use inappropriately 30 year hypothesize select artemisinin-resistant parasite ( slow PCRs ) . To investigate potential contribution human factor artemisinin resistance phenotype , identify study site Eastern Cambodia artemisinin-resistant parasite believe present . The main aim study 1 ) determine whether artemisinin resistance phenotype ( i.e. , half-life long 2-hour half-life observe Wang Pha ) present Eastern Cambodia , 2 ) determine whether hemoglobin E affect parasite clearance rate vivo , 3 ) determine whether age-associated acquire immunity affect parasite clearance rate vivo , 4 ) identify parasite-heritable trait associate slow parasite clearance rate vivo . To meet aim , conduct prospective , longitudinal study recruit Cambodian resident Lumphat District Ratanakiri Province complain fever and/or symptom malaria . Patients diagnose uncomplicated malaria treat weight-based dos artesunate give orally day 3 day follow mefloquine give orally 2 day . During time , finger prick blood smear obtain every 6 hour parasite density zero . From data , estimate parasite clearance rate use half-life parameter . We also collect parasitized red blood cell sample malaria patient prior antimalarial drug administration . These parasite test short-term vitro culture experiment determine susceptibility artemisinins antimalarial drug .</detailed_description>
	<mesh_term>Malaria</mesh_term>
	<mesh_term>Artesunate</mesh_term>
	<criteria>INCLUSION CRITERIA : Age 2 65 year , inclusive Uncomplicated P. falciparum malaria . Tympanic temperature great equal 37.5 degree C history fever within last 24 h. P. calciparum asexual parasite density 10,000 200,000/microL , Inclusive . Willingness allow storage blood sample collect part study . Willingness ability patient/guardians comply protocol duration study . EXCLUSION CRITERIA : Severe malaria : diminish consciousness , respiratory distress , severe prostration , anuria , jaundice , hemoglobinuria , repetitive vomiting , cessation eat drinking . Nonmalaria etiology febrile illness ( e.g. , respiratory tract infection ) evident clinical examination . Hematocrit &lt; 25 percent Treatment present symptom artemisinin compound artemisininbased combination therapy within previous 7 day . Pregnancy breastfeed History allergy know contraindication artemisinins piperaquine Splenectomy .</criteria>
	<gender>All</gender>
	<minimum_age>1 Year</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 11, 2013</verification_date>
	<keyword>Artemisinin</keyword>
	<keyword>Malaria</keyword>
	<keyword>Drug Resistance</keyword>
	<keyword>Hemoglobin E</keyword>
</DOC>